These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 28254353)

  • 1. Bacterial Inclusion Bodies: Discovering Their Better Half.
    Rinas U; Garcia-Fruitós E; Corchero JL; Vázquez E; Seras-Franzoso J; Villaverde A
    Trends Biochem Sci; 2017 Sep; 42(9):726-737. PubMed ID: 28254353
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bacterial inclusion bodies are industrially exploitable amyloids.
    de Marco A; Ferrer-Miralles N; Garcia-Fruitós E; Mitraki A; Peternel S; Rinas U; Trujillo-Roldán MA; Valdez-Cruz NA; Vázquez E; Villaverde A
    FEMS Microbiol Rev; 2019 Jan; 43(1):53-72. PubMed ID: 30357330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bacterial inclusion bodies: making gold from waste.
    García-Fruitós E; Vázquez E; Díez-Gil C; Corchero JL; Seras-Franzoso J; Ratera I; Veciana J; Villaverde A
    Trends Biotechnol; 2012 Feb; 30(2):65-70. PubMed ID: 22037492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bacterial mimetics of endocrine secretory granules as immobilized in vivo depots for functional protein drugs.
    Céspedes MV; Fernández Y; Unzueta U; Mendoza R; Seras-Franzoso J; Sánchez-Chardi A; Álamo P; Toledo-Rubio V; Ferrer-Miralles N; Vázquez E; Schwartz S; Abasolo I; Corchero JL; Mangues R; Villaverde A
    Sci Rep; 2016 Oct; 6():35765. PubMed ID: 27775083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies on bacterial inclusion bodies.
    de Groot NS; Espargaró A; Morell M; Ventura S
    Future Microbiol; 2008 Aug; 3(4):423-35. PubMed ID: 18651814
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Supramolecular organization of protein-releasing functional amyloids solved in bacterial inclusion bodies.
    Cano-Garrido O; Rodríguez-Carmona E; Díez-Gil C; Vázquez E; Elizondo E; Cubarsi R; Seras-Franzoso J; Corchero JL; Rinas U; Ratera I; Ventosa N; Veciana J; Villaverde A; García-Fruitós E
    Acta Biomater; 2013 Apr; 9(4):6134-42. PubMed ID: 23220450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Engineering Secretory Amyloids for Remote and Highly Selective Destruction of Metastatic Foci.
    Céspedes MV; Cano-Garrido O; Álamo P; Sala R; Gallardo A; Serna N; Falgàs A; Voltà-Durán E; Casanova I; Sánchez-Chardi A; López-Laguna H; Sánchez-García L; Sánchez JM; Unzueta U; Vázquez E; Mangues R; Villaverde A
    Adv Mater; 2020 Feb; 32(7):e1907348. PubMed ID: 31879981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isolation of cell-free bacterial inclusion bodies.
    Rodríguez-Carmona E; Cano-Garrido O; Seras-Franzoso J; Villaverde A; García-Fruitós E
    Microb Cell Fact; 2010 Sep; 9():71. PubMed ID: 20849629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bacterial inclusion bodies: an emerging platform for drug delivery and cell therapy.
    Villaverde A
    Nanomedicine (Lond); 2012 Sep; 7(9):1277-9. PubMed ID: 22994952
    [No Abstract]   [Full Text] [Related]  

  • 10. Amyloid-like properties of bacterial inclusion bodies.
    Carrió M; González-Montalbán N; Vera A; Villaverde A; Ventura S
    J Mol Biol; 2005 Apr; 347(5):1025-37. PubMed ID: 15784261
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insoluble protein applications: the use of bacterial inclusion bodies as biocatalysts.
    Hrabárová E; Achbergerová L; Nahálka J
    Methods Mol Biol; 2015; 1258():411-22. PubMed ID: 25447879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How to break recombinant bacteria: does it matter?
    Rodríguez-Carmona E; Villaverde A; García-Fruitós E
    Bioeng Bugs; 2011; 2(4):222-5. PubMed ID: 21829098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Packaging protein drugs as bacterial inclusion bodies for therapeutic applications.
    Villaverde A; García-Fruitós E; Rinas U; Seras-Franzoso J; Kosoy A; Corchero JL; Vazquez E
    Microb Cell Fact; 2012 Jun; 11():76. PubMed ID: 22686540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein aggregation in recombinant bacteria: biological role of inclusion bodies.
    Villaverde A; Carrió MM
    Biotechnol Lett; 2003 Sep; 25(17):1385-95. PubMed ID: 14514038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In situ protein folding and activation in bacterial inclusion bodies.
    Gonzalez-Montalban N; Natalello A; García-Fruitós E; Villaverde A; Doglia SM
    Biotechnol Bioeng; 2008 Jul; 100(4):797-802. PubMed ID: 18351678
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Construction and deconstruction of bacterial inclusion bodies.
    Carrió MM; Villaverde A
    J Biotechnol; 2002 Jun; 96(1):3-12. PubMed ID: 12142138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bacterial inclusion body purification.
    Seras-Franzoso J; Peternel S; Cano-Garrido O; Villaverde A; García-Fruitós E
    Methods Mol Biol; 2015; 1258():293-305. PubMed ID: 25447871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Solid-state NMR spectroscopy reveals that E. coli inclusion bodies of HET-s(218-289) are amyloids.
    Wasmer C; Benkemoun L; Sabaté R; Steinmetz MO; Coulary-Salin B; Wang L; Riek R; Saupe SJ; Meier BH
    Angew Chem Int Ed Engl; 2009; 48(26):4858-60. PubMed ID: 19472238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isolation of biologically active nanomaterial (inclusion bodies) from bacterial cells.
    Peternel S; Komel R
    Microb Cell Fact; 2010 Sep; 9():66. PubMed ID: 20831775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Engineering tumor cell targeting in nanoscale amyloidal materials.
    Unzueta U; Seras-Franzoso J; Céspedes MV; Saccardo P; Cortés F; Rueda F; Garcia-Fruitós E; Ferrer-Miralles N; Mangues R; Vázquez E; Villaverde A
    Nanotechnology; 2017 Jan; 28(1):015102. PubMed ID: 27893441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.